The Black Swan Research Initiative™ (BSRI™) is led by a multi-national consortium of leading myeloma experts who see that the opportunity to cure the first cohort of patients is now within reach. Initial work began in the summer of 2012. Now with the full launch, the initiative will result in new testing capabilities and new clinical trials before the end of this year.
"Just as people who had only seen white swans could not imagine the existence of black swans, until very recently we could not even consider the possibility of a cure," said Susie Novis, President and Co-founder of the IMF. "But now, we have created a paradigm shift by taking an entirely new approach to finding a cure, one we couldn’t even imagine before. We may actually see the first myeloma patients restored to a normal, healthy life, free of their cancer for the first time ever."